Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-18

Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating umbilical cord mesenchymal stem cell therapy for Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cell Treatment (Umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: COMPLETED